×
About 3,130 results

ALLMedicine™ Hyperhidrosis Center

Research & Reviews  876 results

Nail Changes Associated With Thyroid Disease
https://www.mdedge.com/dermatology/article/256823/hair-nails/nail-changes-associated-thyroid-disease
Angela Rosenberg, OMS-IV, Shari R. Lipner, MD, PhD

Aug 4th, 2022 - The major classifications of thyroid disease include hyperthyroidism, which is seen in Graves disease, and hypothyroidism due to iodine deficiency and Hashimoto thyroiditis, which have potentially devastating health consequences. The prevalence of.

Intradermal Botulinum Toxin A Injection Versus Topical 2% Glycopyrrolate for the Treatm...
https://doi.org/10.1097/DSS.0000000000003490
Dermatologic Surgery : Official Publication for American ... Nofal E, Salem S et. al.

Aug 3rd, 2022 - Facial hyperhidrosis (HH), a common problem with both cosmetic and psychological impact, interferes with quality of life. Wide range of treatment options is available for HH. Finding the most effective and yet a safe, tolerable option is the main ...

Real sweating in a virtual stress environment: Investigation of the stress reactivity i...
https://doi.org/10.1371/journal.pone.0272247
PloS One; Schote AB, Dietrich K et. al.

Aug 3rd, 2022 - Hyperhidrosis (excessive sweating, OMIM %114110) is a complex disorder with multifactorial causes. Emotional strains and social stress increase symptoms and lead to a vicious circle. Previously, we showed significantly higher depression scores, an...

Blaschkoid expansive eccrine nevus with a trace of hyperhidrosis confirmed by a sensiti...
https://doi.org/10.1684/ejd.2022.4250
European Journal of Dermatology : EJD; Tomura Y, Noto M et. al.

Jul 23rd, 2022 - Blaschkoid expansive eccrine nevus with a trace of hyperhidrosis confirmed by a sensitivity-reduced iodine-starch test|2022|Tomura Y,Noto M,Komatsuda E,Nitta Y,Ishikawa N,|

Focal Palmoplantar Keratoderma and Gingival Keratosis Caused by a KRT16 Mutation
https://www.mdedge.com/dermatology/article/256402/rare-diseases/focal-palmoplantar-keratoderma-and-gingival-keratosis
Theodore D. Zaki, MD, Lynn M. Boyden, PhD et. al.

Jul 20th, 2022 - To the Editor: Focal palmoplantar keratoderma and gingival keratosis (FPGK)(Online Mendelian Inheritance in Man [OMIM] 148730) is a rare autosomal-dominant syndrome featuring focal, pressure-related, painful palmoplantar keratoderma and gingival h.

see more →

Drugs  82 results see all →

Clinicaltrials.gov  107 results

Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis
https://clinicaltrials.gov/ct2/show/NCT05057117

Jul 13th, 2022 - This trial aims is to assess and compare treatment effect of microwave thermolysis and botulinum toxin A for axillary hyperhidrosis with focus on longevity. The investigators also aim to assess patient satisfaction and adverse reactions in relatio...

Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of...
https://clinicaltrials.gov/ct2/show/NCT03658616

Mar 18th, 2022 - The aim of this study is to investigate the efficacy and safety of 1% GPB cream after 4 weeks of treatment compared with placebo with a sufficient number of patients to obtain statistically significant results, and to assess the long-term safety o...

Qbrexza Cloths for Hyperhidrosis of Amputation Sites
https://clinicaltrials.gov/ct2/show/NCT04924036

Feb 10th, 2022 - BACKGROUND: Approximately 1 in 190 people in the United States have experienced a limb amputation. Of these patients with amputations, over sixty percent suffer from hyperhidrosis at the amputation site. Amputation site hyperhidrosis interferes wi...

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)
https://clinicaltrials.gov/ct2/show/NCT03836287

Jan 25th, 2022 - This is a multicenter, randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of topically applied sofpironium bromide, 15% gel in subjects with axillary hyperhidrosis. Safety will be assessed through collection of ...

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
https://clinicaltrials.gov/ct2/show/NCT03948646

Jan 25th, 2022 - This is a multicenter, randomized, double-blind, vehicle-controlled study to evaluate the safety and efficacy of topically applied sofpironium bromide, 15% gel in subjects with axillary hyperhidrosis. Safety will be assessed through collection of ...

see more →

News  182 results

Nail Changes Associated With Thyroid Disease
https://www.mdedge.com/dermatology/article/256823/hair-nails/nail-changes-associated-thyroid-disease
Angela Rosenberg, OMS-IV, Shari R. Lipner, MD, PhD

Aug 4th, 2022 - The major classifications of thyroid disease include hyperthyroidism, which is seen in Graves disease, and hypothyroidism due to iodine deficiency and Hashimoto thyroiditis, which have potentially devastating health consequences. The prevalence of.

Focal Palmoplantar Keratoderma and Gingival Keratosis Caused by a KRT16 Mutation
https://www.mdedge.com/dermatology/article/256402/rare-diseases/focal-palmoplantar-keratoderma-and-gingival-keratosis
Theodore D. Zaki, MD, Lynn M. Boyden, PhD et. al.

Jul 20th, 2022 - To the Editor: Focal palmoplantar keratoderma and gingival keratosis (FPGK)(Online Mendelian Inheritance in Man [OMIM] 148730) is a rare autosomal-dominant syndrome featuring focal, pressure-related, painful palmoplantar keratoderma and gingival h.

Adhesive Tape to Guide Injection Depth of Botulinum Toxin for Axillary Hyperhidrosis
https://www.mdedge.com/dermatology/article/255261/aesthetic-dermatology/adhesive-tape-guide-injection-depth-botulinum-toxin
Jamison A. Harvey, MD, David L. Swanson, MD

Jun 7th, 2022 - Practice Gap OnabotulinumtoxinA is a US Food and Drug Administration–approved second-line treatment of axillary hyperhidrosis, with a long-term success rate greater than 80% and minimal adverse effects. 1 The recommended depth and angle of injectio.

What’s ahead for laser-assisted drug delivery?
https://www.mdedge.com/dermatology/article/255160/dermatologic-surgery/whats-ahead-laser-assisted-drug-delivery
Doug Brunk

Jun 2nd, 2022 - SAN DIEGO – Twelve years ago, Merete Haedersdal, MD, PhD, and colleagues published data from a swine study, which showed for the first time that the ablative fractional laser can be used to boost the uptake of drugs into the skin. That discovery p.

Botulinum toxin for chronic pain: What's on the horizon?
https://www.mdedge.com/familymedicine/article/248633/musculoskeletal-disorders/botulinum-toxin-chronic-pain-whats-horizon
MDedge Family Medicine; Caleb Dickison, DO, CAQSM, Jeffrey C. Leggit, MD, CAQSM

Nov 12th, 2021 - Botulinum toxin (BoNT) was first approved by the US Food and Drug Administration (FDA) for the treatment of strabismus and blepharospasm in 1989. Since then, approved indications have expanded to include spasticity, cervical dystonia, severe axill.

see more →

Patient Education  5 results see all →